A major bottleneck in curing HIV (human immunodeficiency virus) is that the virus can hide in an inactive form within resting white blood cells, which play a crucial role in coordinating the immune response.
BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system.
Mass General Brigham researchers are shining a powerful new light into the viral darkness with the development of Luminescence CAscade-based Sensor (LUCAS), a rapid, portable, highly-sensitive diagnostic tool for processing complex biological samples.
Researchers gave participants face tattoos that can track when their brain is working too hard. Published in the journal Device, the study introduces a non-permanent wireless forehead e-tattoo that decodes brainwaves to measure mental strain without bulky headgear.
Mapping a human cell gives researchers a view of subcellular architecture and sheds light on how cancer develops.
A new device that monitors the waste-removal system of the brain may help to prevent Alzheimer’s and other neurological diseases, according to a study published today in Nature Biomedical Engineering.
Associate Professor Dr. Hadi Mohammadi runs the Heart Valve Performance Laboratory at UBCO’s School of Engineering. He, along with Dr. Dylan Goode, has been testing an MHV created in their lab that may—after clinical trials—supersede mechanical valves currently available for people living with heart disease.
Researchers at the University of Southern California and other institutes recently developed a new flexible, wireless and battery-free implantable stimulator that could overcome some of the limitations of previously introduced pain-management solutions.
In biomedical research, so-called organs-on-a-chip, also referred to as microphysiological systems, are becoming increasingly important: by cultivating tissue structures in precisely controlled microfluidic chips, it is possible to conduct research much more accurately than in experiments involving living humans or animals. These systems can be used to investigate the effects of a new drug and to better understand the interaction between different organs to grasp the systemic response.
Canadian scientists have developed a blood test and portable device that can determine the onset of sepsis faster and more accurately than existing methods.